Literature DB >> 225282

Growth of diploid, Epstein-Barr virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions.

B Giovanella, K Nilsson, L Zech, O Yim, G Klein, J S Stehlin.   

Abstract

Human Epstein-Barr virus-carrying lymphoid cell lines which have been classified on the basis of studies on clonality and morphological, chromosomal and functional parameters as lymphoblastoid cell lines (LCL) of presumed non-neoplastic origin were inoculated intracerebrally into nude mice. All eighteen of them grew, killing the host mice within 7 to 25 days, except for 2 which grew more slowly. At autopsy, the brain of the nudes was found to be invaded by infiltrating lymphomas. Sixteen of these lymphomas, when recultured in vitro, gave rise to cell lines with growth properties and morphology indistinguishable from those of the inoculated LCL. Chromosomal examinations showed that 3/7 cell lines injected, which grew as lymphomas in the brain, were still normal diploid on reexplantation whereas the remaining four had become aneuploid. Four lines derived from intracerebral lymphomas (2 diploid, 1 aneuploid and 1 untested) were inoculated subcutaneously into adult nude mice. None of them grew. When the corresponding four original LCL lines were inoculated subcutaneously into newborn nude mice, they grew rapidly, but failed to do so in newborn normal mice or intracerebrally in adult normal mice. One such line, U-1450, was treated with anti-lymphocyte serum (ALS). Small nodules developed at the site of inoculation. From one nodule a cell line was cultured, 1450 ALSAD. It was morphologically indistinguishable from the line of origin. The lines obtained from nude mice inoculated with polyclonal LCL seem to have a restricted clonal representation, but were not monoclonal, as evidenced by analyses of their pattern of immunoglobulin synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225282     DOI: 10.1002/ijc.2910240118

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Epstein-Barr virus-transformed pro-B cells are prone to illegitimate recombination between the switch region of the mu chain gene and other chromosomes.

Authors:  E Altiok; G Klein; L Zech; M Uno; B E Henriksson; S Battat; Y Ono; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein.

Authors:  K P Mann; D Thorley-Lawson
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

Review 3.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

Review 4.  Mosaicism in health and disease - clones picking up speed.

Authors:  Lars A Forsberg; David Gisselsson; Jan P Dumanski
Journal:  Nat Rev Genet       Date:  2016-12-12       Impact factor: 53.242

5.  High recurrence of rearrangements involving chromosome 14 in an ataxia telangiectasia lymphoblastoid cell line and in its mutagen-treated derivatives.

Authors:  D Lefrançois; N Kokalj; E Viegas-Péquignot; L Montagnier; B Dutrillaux
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

Review 6.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

7.  A comparison of expression of neoplastic potential of carcinogen-transformed human fibroblasts in nude mice and in chick embryonic skin.

Authors:  J Donahoe; I Noyes; G E Milo; S E Weisbrode
Journal:  In Vitro       Date:  1982-05

8.  Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia.

Authors:  A K Saemundsen; A I Berkel; W Henle; G Henle; M Anvret; O Sanal; F Ersoy; M Cağlar; G Klein
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

9.  Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.

Authors:  P S Randhawa; A Zeevi; C Alvares; S Gollin; R Agostini; E Yunis; S Saidman; L Contis; A J Demetris; M A Nalesnik
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

10.  Hodgkin's disease: establishment and characterization of four in vitro cell lies.

Authors:  V Diehl; H H Kirchner; M Schaadt; C Fonatsch; H Stein; J Gerdes; C Boie
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.